Literature DB >> 18028052

The 120 kDa cell-binding fragment of fibronectin up-regulates migration of alphavbeta6-expressing cells by increasing matrix metalloproteinase-2 and -9 secretion.

Nadia Al-Hazmi1, Gareth J Thomas, Paul M Speight, Simon A Whawell.   

Abstract

Changes in the extracellular matrix, integrin expression, and protease secretion occur in wound healing and cancer and these systems are thought to play a crucial role in such processes. In this study, experiments were performed to examine the interaction of epithelial cells with the 120 kDa cell-binding fibronectin fragment. Cell migration was significantly increased in response to the 120 kDa fragment when compared with the full-length molecule, but only in cells overexpressing the beta-6 integrin (VB6). This involved the up-regulation of matrix metalloproteinases (MMPs) 2 and 9, the levels of which are increased in the supernatant from VB6 cells plated on the 120 kDa fragment. Inhibition of MMP activity with both tissue inhibitor of metalloproteinase-1 (TIMP-1) and a chemical inhibitor (Ro32-3580) resulted in a significant reduction in migration on the fibronectin fragment. In vitro this fragment can be generated by incubating full-length fibronectin with purified MMP-9. Expression of the beta6 integrin subunit, which is only seen in wound healing and cancer, enhances the motility of and MMP secretion by epithelial cells in response to the 120 kDa fibronectin fragment. These enzymes can then further degrade fibronectin to generate additional fragments, leading to the creation of a positive feedback loop, which may be of significance in disease processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028052     DOI: 10.1111/j.1600-0722.2007.00481.x

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  6 in total

1.  Fragmentation of fibronectin by inherent autolytic and matrix metalloproteinase activities.

Authors:  Bjorn Steffensen; Zhihua Chen; Sanjay Pal; Margarita Mikhailova; Jianrong Su; Yao Wang; Xiaoping Xu
Journal:  Matrix Biol       Date:  2010-10-13       Impact factor: 11.583

Review 2.  Defining the role of integrin alphavbeta6 in cancer.

Authors:  A Bandyopadhyay; S Raghavan
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

3.  A novel synthetic oleanane triterpenoid suppresses adhesion, migration, and invasion of highly metastatic melanoma cells by modulating gelatinase signaling axis.

Authors:  Dona Sinha; Kaustav Dutta; Kirat K Ganguly; Jaydip Biswas; Anupam Bishayee
Journal:  Mol Carcinog       Date:  2014-02-10       Impact factor: 4.784

4.  Contribution of the Transcription Factors Sp1/Sp3 and AP-1 to Clusterin Gene Expression during Corneal Wound Healing of Tissue-Engineered Human Corneas.

Authors:  Christelle Gross; Gaëtan Le-Bel; Pascale Desjardins; Manel Benhassine; Lucie Germain; Sylvain L Guérin
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

5.  The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.

Authors:  Sittichai Koontongkaew
Journal:  J Cancer       Date:  2013-01-01       Impact factor: 4.207

Review 6.  Exploring the Role of RGD-Recognizing Integrins in Cancer.

Authors:  Markus Nieberler; Ute Reuning; Florian Reichart; Johannes Notni; Hans-Jürgen Wester; Markus Schwaiger; Michael Weinmüller; Andreas Räder; Katja Steiger; Horst Kessler
Journal:  Cancers (Basel)       Date:  2017-09-04       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.